AI Portfolio Summary
In 2025 Q4, Sanofi maintained a portfolio of 10 distinct positions. The most significant new addition to the portfolio was MapLight Therapeutic, which now represents 5.16% of the total fund value. Conversely, Sanofi completely exited their position in Omada Health Inc..
Total Positions
10
Quarter
2025 Q4
Top Holding
MGTX (31.2%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-10 of 10
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MGTX
MeiraGTx Holdin...
|
Healthcare | 31.24% | 38.56% |
#1
Prev: #1
|
7.0 | no change | no change |
P
S
|
12,197,737 | $96,972,009 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INBX
Inhibrx Bioscie...
|
Healthcare | 29.47% | 14.98% |
#2
1
Prev: #3
|
6.5 | no change | no change |
P
S
|
1,157,926 | $91,476,154 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NVAX
Novavax
|
Healthcare | 14.90% | 22.91% |
#3
1
Prev: #2
|
6.0 | no change | no change |
P
S
|
6,880,481 | $46,236,832 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANAB
AnaptysBio
|
Healthcare | 12.84% | 9.67% |
#4
Prev: #4
|
5.5 | no change | no change |
P
S
|
821,917 | $39,846,536 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMRX
Immuneering Cor...
|
Healthcare | 5.74% | 7.28% |
#5
Prev: #5
|
3.8 | no change | no change |
P
S
|
2,708,559 | $17,822,318 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MPLT
MapLight Therap...
|
Healthcare | 5.16% | — |
#6
Prev: #—
|
5.6 | 912,041 | no change |
NEW
|
912,041 | $16,020,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELDN
Eledon
|
Healthcare | 0.40% | 0.81% |
#7
1
Prev: #8
|
1.2 | no change | no change |
P
S
|
814,980 | $1,230,620 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QTTB
Q32 Bio Inc.
|
Healthcare | 0.26% | 0.19% |
#8
1
Prev: #9
|
1.1 | no change | no change |
P
S
|
244,083 | $810,356 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OMDA
Omada Health In...
|
Healthcare | 0.00% | 4.46% |
Sold All 😨
(Was: #6) |
0.0 | -524,903 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LVTX
LAVA Therapeuti...
|
Unknown | 0.00% | 1.15% |
Sold All 😨
(Was: #7) |
0.0 | -1,919,455 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-10 of 10 holdings